Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2026)

Aquestive Therapeutics has reported Debt Ratio for 10 years, with the latest figure at 0.42 in Q2 2026.

• On a quarterly basis, Debt Ratio rose 11.46% year-over-year to 0.42 in Q2 2026; TTM through Jun 2026 was 0.42, a 11.46% increase from a year earlier, with the FY2025 full-year figure at 0.23, down 27.08% from the prior year.
• Debt Ratio was 0.42 for Q2 2026 at Aquestive Therapeutics, roughly flat from 0.42 in the prior quarter.
• The five-year high for Debt Ratio was 1.02 in Q3 2022, with the low at 0.22 in Q3 2025.
• Average Debt Ratio over 5 years is 0.55, with a median of 0.42 recorded in 2026.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio soared 64.91% in 2022, then plunged 49.75% in 2024.
• Over 5 years, Debt Ratio stood at 0.91 in 2022, then sank by 47.53% to 0.48 in 2023, then plunged by 33.11% to 0.32 in 2024, then declined by 27.08% to 0.23 in 2025, then soared by 78.15% to 0.42 in 2026.
• The last three Debt Ratio figures came in at 0.42 (Q2 2026), 0.42 (Q1 2026), and 0.23 (Q4 2025), per Business Quant data.